M&A Deal Summary

Clinisupplies Acquires Renew - Aquaflush Transanal Irrigation Business

On October 26, 2023, Clinisupplies acquired medical products company Renew - Aquaflush Transanal Irrigation Business from Renew Medical

Acquisition Highlights
  • This is Clinisupplies’ 1st transaction in the Medical Products sector.
  • This is Clinisupplies’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2023-10-26
Target Renew - Aquaflush Transanal Irrigation Business
Sector Medical Products
Buyer(s) Clinisupplies
Sellers(s) Renew Medical
Deal Type Divestiture

Target

Renew - Aquaflush Transanal Irrigation Business

United Kingdom
Renew's Aquaflush Transanal Irrigation (TAI) Business is a manufacturer of medical products.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Clinisupplies

Watford, United Kingdom

Category Company
Sector Manufacturing
DESCRIPTION

Clinisupplies is a manufacturer and supplier of medical appliances specializing in continence products for managing acute and chronic conditions. The company also offers a portfolio of bandages and garments for the treatment of wounds and chronic skin conditions. Clinisupplies supplies its products to the NHS and delivers directly to patients’ homes through Clinidirect, its dispensing appliance contractor. Clinisupplies is based in Watford, United Kingdom.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

Renew Medical

London, United Kingdom

Category Company
Sector Medical Products
DESCRIPTION

Renew Medical is a medical device company specialising in the development and supply of bowel management products, and is based in London, England.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2023 M&A 1 of 1